Dr. Merideth to present on women’s health issues related to Hermansky-Pudlak Syndrome at the 2017 HPS Network Conference

Mar 2, 2017

Dr. Melissa Merideth will meet with those interested in learning more about how women’s health issues are impacted by Hermansky-Pudlak Syndrome at the 24th Annual HPS Network Conference, to be held March 10 – 12, at the Long Island Marriott in Uniondale, N.Y. Her session will be held Saturday afternoon, March 11.

Dr. Merideth has seen well more than 100 women with HPS at NIH. A genetics researcher at the National Institutes of Health, Dr. Merideth is board certified in Obstetrics/Gynecology, Clinical Genetics and Biochemical Genetics.  Dr. Merideth finished her ob/gyn residency at the Mayo Clinic in 2001, and after practicing in Arizona for two years, headed to the NIH in 2003, where she completed fellowships in Clinical and Biochemical Genetics. She works as a gynecologist and geneticist for the NIH Intramural Office of Rare Diseases at the National Human Genome Research Institute. She is also an HPS Network Doctor of the Year.